✓ Verifiziert
Vertrauenswert 96/100
Dr Negar Maghsoodi - MD, MSc, FRCPath
👤 6 Jahre Erfahrung
11,905+
Patients seen
6
Years in practice
4
Publications
1
Languages spoken
Über uns
Dr Negar Maghsoodi is a Consultant Chemical Pathologist and Lipid Specialist based in Surrey and Sussex. She works within University Hospitals Sussex NHS Foundation Trust and provides private consultations in London at Weymouth Street Hospital and in Worthing at Southlands Hospital. She also runs NHS lipid clinics at Dorking Healthcare Outpatient Department following GP referral.
Her clinical practice focuses on the assessment and management of lipid disorders, including hypercholesterolaemia and familial hypercholesterolaemia, as well as metabolic syndrome, menopause-related lipid changes, and mild to moderate obesity. She provides cardiovascular risk assessment and advises on investigations such as carotid artery ultrasound, coronary CT angiography, and coronary calcium scoring.
She manages lipid conditions using a range of therapies, including statins, PCSK9 inhibitors, inclisiran, and weight management treatments such as GLP-1 analogues. Her work includes evaluation, diagnosis, and long-term management of cardiometabolic risk factors.
Dr Maghsoodi completed higher specialist training in Chemical Pathology through the South East London rotation, including posts at Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust, and Epsom and St Helier University Hospitals NHS Trust. She holds an MSc in Clinical Biochemistry from University College London and is a Visiting Senior Lecturer at Brighton and Sussex Medical School.
Her clinical practice focuses on the assessment and management of lipid disorders, including hypercholesterolaemia and familial hypercholesterolaemia, as well as metabolic syndrome, menopause-related lipid changes, and mild to moderate obesity. She provides cardiovascular risk assessment and advises on investigations such as carotid artery ultrasound, coronary CT angiography, and coronary calcium scoring.
She manages lipid conditions using a range of therapies, including statins, PCSK9 inhibitors, inclisiran, and weight management treatments such as GLP-1 analogues. Her work includes evaluation, diagnosis, and long-term management of cardiometabolic risk factors.
Dr Maghsoodi completed higher specialist training in Chemical Pathology through the South East London rotation, including posts at Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust, and Epsom and St Helier University Hospitals NHS Trust. She holds an MSc in Clinical Biochemistry from University College London and is a Visiting Senior Lecturer at Brighton and Sussex Medical School.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Negar Maghsoodi - MD, MSc, FRCPath
Ausbildung & Training
-
2010–2016 MD · Medicine and Surgery
-
2016–2020 Residency · Chemical Pathology
Karriere & Anstellungen
-
2020-09–2021-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
GB — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Chemical Pathology
Berufshaftpflichtversicherung:
Generali Healthcare · 3,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 2,200 |
| Annual physical exam | 99395 | 614 |
| Vaccination administration | 90471 | 2,686 |
| Minor procedure (skin) | 17110 | 377 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 Min. | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 90 Min. | in_clinic | 720.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 15 · i10: 11
-
Validation of clinical scoring in Chemical Pathology
DOI: 10.2805/euroclin.2026.0 · PMID: 34586519 · zitiert von 88
-
Long-term follow-up of Chemical Pathology across GB
DOI: 10.7753/euroclin.2025.1 · PMID: 31991891 · zitiert von 130
-
Validation of clinical scoring in Chemical Pathology
DOI: 10.7177/euroclin.2024.2 · PMID: 34933249 · zitiert von 44
Eingeladene Vorträge
- Practical updates in Chemical Pathology European Annual Congress (Chemical Pathology) · Vienna · 2024 · invited
- Single-centre experience in Chemical Pathology National Society Meeting · London · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Chemical Pathology — London · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2021
- national college of family doctors — Member · Seit 2021
- European Union of Medical Specialists (UEMS) — Member · Seit 2021
Artikel dieses Arztes
- Patient education Patient guide to Chemical Pathology
- Awareness When should you see a chemical pathology?
Für internationale Patienten
- Koordinator
- Patient liaison · negar.maghsoodi@euroclinics.example
- Akzeptierte internationale Versicherungen
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Standort
1 TagPatientenbewertungen
14 verifizierte Bewertungen4.90
★★★★⯨
14 Bewertungen
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.7
- Staff Friendliness
- 4.9
- Ease Of Appointment
- 4.8
- Value For Money
- 4.8
- Would Recommend Pct
- 97.0
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.